Valia is the brother-in-law of Sun Pharma helmsman Dilip Shanghvi. The Indian drugmaker has yet to announce which unit will take over the business but said the change will happen by the first quarter of its 2020 fiscal year, or by June 2019. Before the Moneylife report, Sun's relationship with the distributor—categorized as a related party—had already come under scrutiny in late 2018. Sun said at the time that it could take the distribution business in house or simply acquire Aditya Medisales out of respect for investor concerns.